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QSARAbstract In the present study, a series of 2/3-bromo-N0-(substituted benzylidene/3-phenylallylid-
ene)benzohydrazides was synthesized and evaluated in vitro for its antimicrobial and anticancer
potentials. The results of antimicrobial and anticancer study indicated that compounds 3, 15 and
18 (pMICam = 1.62 lM/ml) were found to be most potent antimicrobial agents and compound 4
(IC50 = 1.88 ± 0.03 lM) was found to be the most potent anticancer agent. The results of QSAR
analysis indicated the importance of topological parameters, Balaban index (J) and valence ﬁrst and
second order molecular connectivity indices (1vv and 2vv) in describing antimicrobial activity of the
synthesized benzohydrazides.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
In recent years, a number of life-threatening infections caused
by multi-drug resistant Gram-positive and Gram-negative
pathogenic bacteria have reached an alarming level in many
countries around the world (Berber et al., 2003). A numberof clinical reports in the United States and worldwide have
independently described the emergence of vancomycin resis-
tance in methicillin-resistance Staphylococcus aureus (MRSA)
isolates and other human pathogen Gram-negative isolates
(Lee and Hecker, 1999). Infections caused by these microor-
ganisms pose a serious challenge to the medical community
and need for an effective therapy has led to a search for novel
antibacterial agents (Akbas et al., 2005).
Cancer is a disease characterized by a shift in the controlled
mechanisms that govern cell proliferation and differentiation.
Malignancy is caused by abnormalities in cells, which might
be due to inherited genes or caused by outside exposure of
the body to chemicals, radiation, or even infectious agents.stituted
hemis-
2 P. Kumar et al.Ideal anticancer drugs would eradicate cancer cells without
harming normal tissues. Unfortunately, no currently available
anticancer agents meet this criterion and clinical use of drugs
involves a weighing of beneﬁts against toxicity in a search of
favorable therapeutic index (Al-Omary et al., 2012).
Similar molecules with just a slight variation in their struc-
tures can have quite different biological activities. This kind of
relationship between molecular structure and changes in bio-
logical activity is the center of focus for the ﬁeld of quantitative
structure–activity relationships (QSAR), the main objective of
which is to investigate these relationships by building mathe-
matical models that explain the relationship in a statistical
way. With the success of its applications, QSAR has become
one of the well-developed areas in computational chemistry
(Jurs and He, 2005).
Keeping this observation in mind and in continuation of
our study on exploring the biological proﬁle of Schiff bases
(Kumar et al., 2010a,b, 2012; Judge et al., 2012a,b; Narang
et al., 2012a,b), we hereby report the synthesis, antimicrobial,
anticancer evaluation and QSAR studies of 2/3-bromo-N0-
(substituted benzylidene/3-phenylallylidene)benzohydrazides
(1–22).
2. Materials and methods
Starting materials were obtained from commercial sources and
were used without further puriﬁcation. Reaction progress was
observed by thin layer chromatography making use of com-
mercial silica gel plates (Merck), Silica gel F254 on aluminum
sheets. Melting points were determined in open capillary tubes
on a Sonar melting point apparatus. 1H and 13C nuclear mag-
netic resonance (1H NMR and 13C) spectra were determined
by a Brucker DRX-300 FTNMR spectrometer in appropriate
deuterated solvents and are expressed in parts per million (d,
ppm) downﬁeld from tetramethylsilane (internal standard).
NMR data are given as multiplicity (s, singlet; d, doublet; t,
triplet; m, multiplet) and number of protons. Infrared (IR)
spectra were recorded on an Agilent Resolutions Pro FTIR
spectrometer. Elemental analysis was performed on a
Perkin–Elmer 2400 C, H, N analyzer. Mass spectra were taken
on Waters Micromass Q-ToF Micro instrument.
2.1. General procedure for the synthesis of 2/3-bromo-N0-
(substituted benzylidene/3-phenylallylidene)benzohydrazides
(1–22)
The mixture of 2/3 benzoic acid (0.08 mol) and ethanol
(0.74 mol) was reﬂuxed in the presence of sulfuric acid till
the completion of reaction. Once the reaction has been com-
pleted, the reaction mixture was added to 200 mL ice cold
water and the ester formed was extracted with ether (50 mL).
The ether layer was separated and this on evaporation yielded
the crude ester which was then recrystallized from alcohol.
Hydrazine-hydrate (99%) (0.015 mol) was added to ethanolic
solution of ester (0.01 mol) and reﬂuxed for 5 h. The reaction
mixture was then cooled and the precipitates were ﬁltered
off, washed with water, dried and recrystallized from ethanol.
A solution of different aldehydes (0.05 mol) in ethanol was
added to a solution of 2/3-bromobenzohydrazide (synthesized
above, 0.05 mol) in 50 mL ethanol. The mixture was reﬂuxed
for 5–7 h. Then the reaction mixture was allowed to cool atPlease cite this article in press as: Kumar, P. et al., Synthesis, antimicrobial,
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ﬁltered, dried and recrystallized from ethanol.
2.2. Evaluation of antimicrobial activity
The antimicrobial activity of the synthesized benzohydrazides
was carried out against Gram-positive bacteria: S. aureus,
Bacillus. subtilis, Gram-negative bacterium: Escherichia coli
and fungal strains: Candida albicans and Aspergillus niger were
determined using the tube dilution method (Cappucino and
Sherman, 1999). Dilutions (50–1.56 lg/ml) of test and stan-
dard (norﬂoxacin and ﬂuconazole for antibacterial and anti-
fungal activities respectively) compounds were prepared in
double strength nutrient broth – I.P. (bacteria) or Sabouraud
dextrose broth I.P. (fungi) (Pharmacopoeia of India, 2007).
The samples were incubated at 37 ± 1 C for 24 h (bacteria),
at 25 ± 1 C for 7d (A. niger) and at 37 ± 1 C for 48 h (C.
albicans), and the results were recorded in terms of MIC (the
lowest concentration of test substance which inhibited the
growth of microorganisms).
2.3. Determination of MBC/MFC
The minimum bactericidal concentration (MBC) and fungi-
cidal concentration (MFC) were determined by subculturing
100 lL of culture from each tube (which remained clear in
the MIC determination) on fresh medium. MBC and MFC
values represent the lowest concentration of compound that
produces a 99.9% end point reduction (Rodriguez-Arguelles
et al., 2005).
2.4. Evaluation of anticancer activity
The anticancer activity of the synthesized compounds (1–22)
was determined against human colon (HCT116) cancer cell
line. The cell line was cultured in RPMI 1640 (Sigma) supple-
mented with 10% heat inactivated fetal bovine serum (FBS)
(PAA Laboratories) and 1% penicillin/streptomycin (PAA
Laboratories). Culture was maintained in a humidiﬁed incuba-
tor at 37 C in an atmosphere of 5% CO2. Anticancer activity
of the synthesized compounds at various concentrations was
assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT) (Sigma) assay, as described by Mos-
mann, but with minor modiﬁcation, following 72 h of
incubation. Assay plates were read using a spectrophotometer
at 520 nm. Data generated were used to plot a dose–response
curve of which the concentration of test compounds required
to kill 50% of cell population (IC50) was determined.
Anticancer activity was expressed as the mean IC50 of three
independent experiments (Mosmann, 1983).
2.5. QSAR studies
The structures of 2/3-bromo-N0-(substituted benzylidene/
3-phenylallylidene)benzohydrazides (1–22) were ﬁrst pre-
optimized with the Molecular Mechanics Force Field
(MM+) procedure included in Hyperchem 6.03 (Hyperchem
6.0, 1993) and the resulting geometries were further reﬁned
by means of the semiempirical method PM3 (Parametric
Method-3). We chose a gradient norm limit of 0.01 kcal/A˚anticancer evaluation and QSAR studies of 2/3-bromo-N0-(substituted
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was used for each molecule to calculate physicochemical prop-
erties using TSAR 3.3 software for Windows (TSAR 3D
Version 3.3, 2000). Further, the regression analysis was
performed using the SPSS software package (SPSS for
Windows, 1999).
3. Results and discussion
3.1. Chemistry
Synthesis of target compounds (1–22) was carried out in
appreciable yield by adopting the synthetic procedures
outlined in Scheme 1. The structures of all the synthesized
compounds (1–22) were ascertained on the basis of their con-
sistent IR, NMR and Mass spectral characteristics in additionR3
R2 R1
COOH
R5R4
EtOH
R3
R2 R1
COOEt
R5R4
R3
R2 R1
CONHN
R5R4
OHC
(1, 20)
S. No. R1 R2 R3 R4 R5 X1
1 H Br H H H -
2 H Br H H H H
3 H Br H H H H
4 H Br H H H OH
5 H Br H H H H
6 H Br H H H H
7 H Br H H H H
8 H Br H H H H
9 Br H H H H H
10 Br H H H H H
11 Br H H H H H
12 Br H H H H H
13 Br H H H H H
14 Br H H H H H
15 Br H H H H H
16 Br H H H H H
17 Br H H H H H
18 Br H H H H H
19 Br H H H H H
20 Br H H H H -
21 Br H H H H H
22 Br H H H H H
Scheme 1 Scheme for the synthesis of 2/3-bromo-N0-(subs
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3.2. Antimicrobial activity
The synthesized compounds were screened for their in vitro
antibacterial activity against S. aureus, B. subtilis, and E. coli
and antifungal activity against C. albicans and A. niger by tube
dilution method (Cappucino and Sherman, 1999) using
norﬂoxacin and ﬂuconazole as reference standards for antibac-
terial and antifungal activities, respectively and the results are
presented in Table 1 which indicated that none of the synthe-
sized compounds exhibited better antimicrobial activity than
standard drugs, norﬂoxacin and ﬂuconazole. Results of
MBC/MFC studies of the synthesized compounds are given
in Table 2.NH2NH2.H2O
R3
R2 R1
CONHNH2
R5R4
OHC X3
X2X1
X5 X4
R3
R2 R1
CONHN
R5R4
X1 X2
X3
X4X5
(2-19, 21, 22)
X2 X3 X4 X5
- - - -
H OCH3 H H
OCH3 OCH3 OCH3 H
H H H H
H Br H H
OCH3 OCH3 H H
OC2H5 OH H H
H N(CH3)2 H H
H H H H
H Cl H H
Cl H H H
H Br H H
H NO2 H H
OCH3 OCH3 H H
H N(CH3)2 H H
H CHO H H
OC2H5 OH H H
OCH3 OCH3 OCH3 H
H OCH3 H H
- - - -
H CH3 H H
OCH3 OH H H
tituted benzylidene/3-phenylallylidene)benzohydrazides.
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Table 1 Antimicrobial (lM/ml) and anticancer (IC50, lM) activity of the synthesized 2/3-bromo-N0-(substituted benzylidene/
3-phenylallylidene)benzohydrazides.
Comp. pMICsa pMICbs pMICec pMICca pMICan pMICab pMICaf pMICam IC50 (lM)
1 1.42 1.72 1.72 1.42 1.42 1.62 1.42 1.54 607.90 ± 0.03
2 1.43 1.73 1.43 1.73 1.43 1.53 1.58 1.55 87.09 ± 0.00
3 1.50 1.80 1.50 1.80 1.50 1.60 1.65 1.62 66.16 ± 0.01
4 1.41 1.71 1.41 2.01 1.41 1.51 1.71 1.59 1.88 ± 0.03
5 1.49 1.79 1.49 1.49 1.49 1.59 1.49 1.55 12.49 ± 0.04
6 1.46 1.76 1.46 1.76 1.46 1.56 1.61 1.58 165.29 ± 0.02
7 1.16 1.46 1.16 1.46 1.16 1.26 1.31 1.28 165.29 ± 0.01
8 1.44 1.74 1.44 1.74 1.44 1.54 1.59 1.56 144.51 ± 0.00
9 1.08 1.38 1.38 1.38 1.08 1.28 1.23 1.26 247.52 ± 0.03
10 1.43 1.73 1.43 1.73 1.43 1.53 1.58 1.55 88.76 ± 0.03
11 1.13 1.43 1.13 1.73 0.83 1.23 1.28 1.25 59.17 ± 0.02
12 1.49 1.79 1.49 1.49 1.79 1.59 1.64 1.61 96.86 ± 0.01
13 1.14 1.44 1.14 1.44 1.44 1.24 1.44 1.32 517.24 ± 0.02
14 1.16 1.46 1.16 1.46 1.16 1.26 1.31 1.28 247.93 ± 0.02
15 1.44 1.74 1.44 1.74 1.74 1.54 1.74 1.62 14.45 ± 0.01
16 1.42 1.72 1.42 1.72 1.12 1.52 1.42 1.48 604.23 ± 0.01
17 1.46 1.76 1.46 1.46 1.46 1.56 1.46 1.52 137.74 ± 0.00
18 1.50 1.80 1.50 1.80 1.50 1.60 1.65 1.62 305.34 ± 0.03
19 1.43 1.73 1.43 1.73 1.43 1.53 1.58 1.55 147.15 ± 0.01
20 1.42 1.72 1.72 1.72 1.42 1.62 1.57 1.60 54.71 ± 0.04
21 1.71 1.71 1.40 1.71 1.40 1.60 1.55 1.58 157.73 ± 0.02
22 1.45 1.75 1.45 1.75 1.45 1.55 1.60 1.57 257.88 ± 0.01
SD 0.16 0.14 0.16 0.17 0.21 0.14 0.14 0.13
Std. 2.61a 2.61a 2.61a 2.64b 2.64b
Tetrandrine 1.53 ± 0.01
5FU 4.60 ± 0.01
Carboplatin >100.00
SD, standard deviation.
a Norﬂoxacin.
b Fluconazole.
Table 2 Minimum bactericidal/fungicidal (lM/ml) activity of 2/3-bromo-N0-(substituted benzylidene/3-phenylallylidene)
benzohydrazides.
Comp. Minimum Bactericidal/Fungicidal Concentration (lM/ml)
S. aureus B. subtilis E. coli C. albicans A. niger
1 >0.15 >0.15 >0.15 >0.15 >0.15
2 >0.15 >0.15 >0.15 >0.15 >0.15
3 >0.13 >0.13 >0.13 >0.13 >0.13
4 >0.16 >0.16 >0.16 >0.16 >0.16
5 >0.13 >0.13 >0.13 >0.13 >0.13
6 >0.14 >0.14 >0.14 >0.14 >0.14
7 >0.14 >0.14 >0.14 >0.14 >0.14
8 >0.14 >0.14 >0.14 >0.14 >0.14
9 >0.17 >0.17 >0.17 >0.17 >0.17
10 >0.15 >0.15 >0.15 >0.15 >0.15
11 >0.15 >0.15 >0.15 >0.15 >0.15
12 >0.13 >0.13 >0.13 >0.13 >0.13
13 >0.14 >0.14 >0.14 >0.14 >0.14
14 >0.14 >0.14 >0.14 >0.14 >0.14
15 >0.14 >0.14 >0.14 >0.14 >0.14
16 >0.15 >0.15 >0.15 >0.15 >0.15
17 >0.14 >0.14 >0.14 >0.14 >0.14
18 >0.13 >0.13 >0.13 >0.13 >0.13
19 >0.15 >0.15 >0.15 >0.15 >0.15
20 >0.15 >0.15 >0.15 >0.15 >0.15
21 >0.16 >0.16 >0.16 >0.16 >0.16
22 >0.14 >0.14 >0.14 >0.14 >0.14
Standard 0.019a 0.019a 0.019a 0.040b 0.040b
a Norﬂoxacin.
b Fluconazole.
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Figure 1 Structural requirements for the antimicrobial and anticancer activities of the synthesized 2/3-bromo-N0-(substituted
benzylidene/3-phenylallylidene)benzohydrazides.
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(pMICsa = 1.71 lM/ml) was found to be most effective
antibacterial agent against S. aureus. In case of B. subtilis,
compounds 3 and 18 (pMICbs = 1.80 lM/ml) emerged as
most effective antibacterial agents. Compounds 1 and 20,
(pMICec = 1.72 lM/ml) exhibited most potent antibacterial
activity against E. coli. In case of antifungal activity against
C. albicans, compound 4 (pMICca = 2.01 lM/ml) was found
to be the most potent antifungal agent, whereas, compound
12 (pMICan = 1.79 lM/ml) exhibited most potent antifungal
activity against A. niger. Overall antimicrobial activity results
(Table 1) indicated that compounds 3, 15 and 18 (pMICam =
1.62 lM/ml) were found to be most potent antimicrobial
agents.
In general, the results of MBC/MFC studies (Table 2)
revealed that the synthesized compounds were bacteriostatic
and fungistatic in action as their MFC and MBC values were
3-fold higher than their MIC values (a drug is considered to be
bacteriosatic/fungistatic when its MFC and MBC values are 3-
fold higher than its MIC value).
3.3. Anticancer activity
The in vitro anticancer activity of the synthesized hydrazide
derivatives was determined against human colorectalTable 3 Values of selected descriptors used in the QSAR studies.
Comp. Log P MR 0vv 1vv 2vv j
1 4.63 85.61 12.28 6.87 4.94 1
2 3.96 81.83 12.46 6.73 4.92 1
3 3.46 94.76 15.12 7.79 5.60 2
4 3.93 77.06 11.50 6.35 4.70 1
5 5.01 82.99 13.05 7.12 5.63 1
6 3.71 88.29 13.79 7.26 5.26 1
7 4.02 88.27 13.54 7.46 5.31 1
8 4.01 89.08 13.50 7.24 5.63 1
9 4.22 75.37 11.13 6.21 4.46 1
10 4.74 80.17 12.25 6.72 5.08 1
11 4.74 80.17 12.25 6.72 5.08 1
12 5.01 82.99 13.05 7.12 5.54 1
13 4.17 82.69 12.32 6.71 4.90 1
14 3.71 88.29 13.79 7.26 5.17 1
15 4.01 89.08 13.50 7.24 5.54 1
16 3.89 81.96 12.04 6.65 4.84 1
17 4.02 88.27 13.54 7.46 5.21 1
18 3.46 94.76 15.12 7.79 5.51 2
19 3.96 81.83 12.46 6.74 4.83 1
20 4.63 85.61 12.28 6.88 4.84 1
21 4.68 80.41 12.05 6.62 4.96 1
22 3.68 83.52 12.83 6.88 4.98 1
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2,5-diphenyl tetrazolium bromide (MTT) assay (Mosmann,
1983) and the results are presented in Table 1. In general, the
synthesized compounds showed moderate anticancer activity
and compounds 2–5, 10–12, 15 and 20 (IC50 = 87.09 ± 0.00,
66.16 ± 0.01, 1.880.03, 12.490.04, 88.76 ± 0.03, 59.17 ±
0.02, 96.86 ± 0.01, 14.45 ± 0.01 and 54.71 ± 0.04 lM respec-
tively) showed better anticancer potential than standard drug
carboplatin (IC50 =>100.00 lM). None of the synthesized
compounds exhibited anticancer potential better than standard
drug tetrandrine (IC50 = 1.53 ± 0.01 lM) as well as 5-ﬂuoro-
uracil (IC50 = 4.60 ± 0.01 lM) except compound 4 (IC50 =
1.880.03 lM) which was found to be the more potent antican-
cer agent than 5-ﬂuorouracil but less potent than tetrandrine.
Thus compound 4 was found to be the most potent anticancer
agent of the series and may be taken as a lead compound for the
development of novel anticancer agents. The structural
requirements for the antimicrobial and anticancer activities of
the synthesized benzohydrazide derivatives are presented in
Fig. 1.
3.4. QSAR studies
In order to identify the substituent effect on the antimicrobial
activity, quantitative structure–activity relationship (QSAR)1 ja1 Te LUMO HOMO l
6.37 14.76 3312.57 0.69 8.79 3.69
6.37 14.98 3505.27 0.48 8.76 3.75
0.31 18.83 4456.71 0.62 8.85 1.17
5.39 14.00 3349.95 0.63 8.95 3.35
5.39 14.51 3369.00 0.75 9.17 2.32
8.34 16.90 3980.97 0.50 8.58 2.64
8.34 16.90 3981.63 0.51 8.66 3.74
7.36 15.96 3561.08 0.38 8.24 5.45
4.41 13.06 3029.30 0.31 8.98 3.09
5.39 14.32 3389.40 0.56 9.02 1.76
5.39 14.32 3389.39 0.51 9.13 2.46
5.39 14.51 3368.90 0.63 9.07 1.73
7.36 15.57 3860.15 1.41 9.60 3.67
8.34 16.90 3980.86 0.31 8.49 2.32
7.36 15.96 3560.97 0.15 8.16 4.97
6.37 14.69 3477.53 0.91 9.23 1.70
8.34 16.90 3981.53 0.33 8.56 2.46
0.31 18.83 4456.61 0.44 8.78 1.98
6.37 14.98 3505.17 0.27 8.66 3.48
6.37 14.76 3312.46 0.59 8.68 2.95
5.39 14.04 3185.17 0.31 8.83 3.68
7.36 15.92 3825.74 0.35 8.60 2.04
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Table 4 Correlation matrix for antibacterial activity of the synthesized benzohydrazides.
pMICab Log P MR
0vv 1vv 2vv j1 ja1 LUMO HOMO l
pMICab 1.000
Log P 0.067 1.000
MR 0.667 0.510 1.000
0vv 0.806 0.403 0.971 1.000
1vv 0.826 0.286 0.954 0.978 1.000
2vv 0.771 0.191 0.704 0.749 0.799 1.000
j1 0.530 0.755 0.921 0.887 0.834 0.398 1.000
ja1 0.618 0.678 0.943 0.932 0.885 0.481 0.993 1.000
LUMO 0.088 0.297 0.310 0.244 0.240 0.105 0.292 0.287 1.000
HOMO 0.133 0.423 0.443 0.316 0.307 0.239 0.385 0.362 0.881 1.000
l 0.469 0.075 0.030 0.164 0.165 0.051 0.155 0.187 0.579 0.737 1.000
6 P. Kumar et al.study was undertaken, using linear free energy relationship
model (LFER) described by Hansch and Fujita (1964).
Biological activity data determined as MIC values were ﬁrst
transformed into pMIC values (i.e. –log MIC) and used as
dependent variable in QSAR study. The values of selected
molecular descriptors used in the QSAR study are presented
in Table 3.
Our earlier studies (Kumar et al., 2012; Judge et al.,
2012a,b; Narang et al., 2012a,b) indicated that the multi-target
QSAR (mt-QSAR) models are better than one-target QSAR
(ot-QSAR) models in describing the antimicrobial activity.
So, in the present study we have developed multi-target QSAR
models to describe the antimicrobial activity of the synthesized
2/3-bromo-N0-(substituted benzylidene/3-phenylallylidene)
benzohydrazides.
In light of above, we have attempted to develop three differ-
ent mt-QSAR models viz. mt-QSAR model for describing anti-
bacterial activity of the synthesized compounds against S.
aureus, B. subtilis and E. coli, mt-QSAR model for describing
antifungal activity of the synthesized compounds against C.
albicans and A. niger as well as a common mt-QSAR model
for describing the antimicrobial (overall antibacterial and anti-
fungal) activity of the synthesized compounds against all the
above mentioned microorganisms.
In order to develop mt-QSAR models, initially we calcu-
lated the average antibacterial, antifungal and antimicrobial
activities of 2/3-bromo-N0-(substituted benzylidene/3-phenyl-
allylidene)benzohydrazides which are presented in Table 1.
During the regression analysis studies, different outliers
were identiﬁed in case of antibacterial, antifungal and antimi-
crobial activities and the QSAR models have been developed
after removal of these outliers (compound numbers in bracket)
i.e. antibacterial (1, 7, 9, 11, 13, 14, 20 and 21), antifungal (4, 5,
7, 9, 11, 14, 15, 19 and 22) and antimicrobial activities (4, 7, 9,
11, 13, 14, 16, 17 and 20). In multivariate statistics, it is com-
mon to deﬁne three types of outliers.
1. X/Y relation outliers are substances for which the relation-
ship between the descriptors (X variables) and the depen-
dent variables (Y variables) is not the same as in the (rest
of the) training data.
2. X outliers are substances whose molecular descriptors do
not lie in the same range as the (rest of the) training data.
3. Y outliers are only deﬁned for training or test samples.
They are substances for which the reference value of
response is invalid.Please cite this article in press as: Kumar, P. et al., Synthesis, antimicrobial,
benzylidene/3-phenylallylidene)benzohydrazidesN0-(substituted benzyliden
try (2014), http://dx.doi.org/10.1016/j.arabjc.2014.05.010As there was no difference in the activity (Table 1) as well
as the molecular descriptor range (Table 3) of these outliers
when compared to the other benzohydrazides, these outliers
belong to the category of Y outliers (Substances for which
the reference value of response is invalid) (Furusjo et al., 2006).
Preliminary analysis was carried out in terms of correlation
analysis. A correlation matrix constructed for antibacterial
activity of the synthesized compounds is presented in Table 4.
In general, high colinearity (r> 0.5) was observed between
different parameters. The high interrelationship was observed
between topological parameters, Kier’s ﬁrst order and alpha
ﬁrst order shape indices (j1 and ja1) (r= 0.993) and low inter-
relationship was observed between steric parameter, molar
refractivity (MR) and electronic parameter, dipole moment
(l) (r= 0.030).
The structural effects on variations in antibacterial activity
of the synthesized benzohydrazides in terms of pMICab were
examined by regression analysis with molecular parameters
shown in Table 3. For 14 benzohydrazides, Eq. (1) was derived
as that of the best quality using the topological parameter,
valence ﬁrst order molecular connectivity index (1vv, r= 0.
826, Table 4).
3.4.1. LR mt-QSAR model for antibacterial activity
pMICab ¼ 0:0590 1vv þ 1:136 ð1Þ
n ¼ 14 r ¼ 0:826 q2 ¼ 0:621 s ¼ 0:0179 F ¼ 25:78
Here and thereafter, n – number of data points, r – correla-
tion coefﬁcient, q2 – cross validated r2 obtained by leave one
out method, s – standard error of the estimate and F – Fischer
statistics.
Coefﬁcient of 1vv in Eq. (1) is positive which indicates that
antibacterial activity of the synthesized compounds is posi-
tively correlated to valence ﬁrst order molecular connectivity
index (1vv) i.e. antibacterial activity of the synthesized com-
pounds will increase with an increase in value of 1vv and vice
versa. This is evidenced by the antibacterial activity data of
the synthesized compounds (Table 1) and their 1vv values
(Table 3) i.e. compounds 3 and 18 having highest 1vv value
of 7.79 are having highest antibacterial activity (pMICab =
1.60 lM/ml) except compounds 1 and 20 (pMICab = 1.62
lM/ml) which were removed as outliers prior to model devel-
opment for antibacterial activity of the synthesized
benzohydrazides.anticancer evaluation and QSAR studies of 2/3-bromo-N0-(substituted
e/3-phenylallylidene)benzohydrazides –>. Arabian Journal of Chemis-
Table 5 Observed, predicted and residual antimicrobial activities of the synthesized compounds obtained by developed QSAR
models.
Comp. pMICab pMICaf pMICam
Obs. Pre. Res. Obs. Pre. Res. Obs. Pre. Res.
1 1.62 1.54 0.08 1.42 1.50 0.08 1.54 1.54 0.00
2 1.53 1.53 0.00 1.58 1.50 0.08 1.55 1.56 0.01
3 1.60 1.61 0.01 1.65 1.63 0.02 1.62 1.62 0.00
4 1.51 1.51 0.00 1.71 1.46 0.25 1.59 1.56 0.03
5 1.59 1.57 0.02 1.49 1.64 0.15 1.55 1.57 0.02
6 1.56 1.56 0.00 1.61 1.57 0.04 1.58 1.59 0.01
7 1.26 1.57 0.31 1.31 1.58 0.27 1.28 1.59 0.31
8 1.54 1.54 0.00 1.59 1.64 0.05 1.56 1.58 0.02
9 1.28 1.50 0.22 1.23 1.41 0.18 1.26 1.55 0.29
10 1.53 1.54 0.01 1.58 1.53 0.05 1.55 1.57 0.02
11 1.23 1.54 0.31 1.28 1.53 0.25 1.25 1.56 0.31
12 1.59 1.57 0.02 1.64 1.62 0.02 1.61 1.58 0.03
13 1.24 1.56 0.32 1.44 1.50 0.06 1.32 1.57 0.25
14 1.26 1.55 0.29 1.31 1.55 0.24 1.28 1.59 0.31
15 1.54 1.54 0.00 1.74 1.62 0.12 1.62 1.58 0.04
16 1.52 1.54 0.02 1.42 1.49 0.07 1.48 1.56 0.08
17 1.56 1.57 0.01 1.46 1.56 0.10 1.52 1.59 0.07
18 1.60 1.60 0.00 1.65 1.62 0.03 1.62 1.63 0.01
19 1.53 1.53 0.00 1.58 1.48 0.10 1.55 1.56 0.01
20 1.62 1.54 0.08 1.57 1.49 0.08 1.60 1.55 0.05
21 1.60 1.52 0.08 1.55 1.51 0.04 1.58 1.56 0.02
22 1.55 1.53 0.02 1.60 1.51 0.09 1.57 1.58 0.01
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Figure 2 Plot of observed pMICab against predicted pMICab by
Eq. (2).
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Figure 3 Plot of observed pMICab against residual pMICab by
Eq. (2).
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logical index proposed by Randic is denoted by v and is
deﬁned as sum of over all the edges (ij) as per following
v ¼
Xn
i¼1
ðVi VjÞ1=2
where Vi and Vj are the degrees of adjacent vertices i and j and
n is the number of vertices in a hydrogen suppressed molecular
structure (Lather and Madan, 2005). The topological index, v
signiﬁes the degree of branching, connectivity of atoms and
unsaturation in the molecule which accounts for variation in
activity (Gupta et al., 2003).
In search of a better QSAR model, we coupled valence ﬁrst
order molecular connectivity index (1vv) with electronic param-Please cite this article in press as: Kumar, P. et al., Synthesis, antimicrobial,
benzylidene/3-phenylallylidene)benzohydrazidesN0-(substituted benzyliden
try (2014), http://dx.doi.org/10.1016/j.arabjc.2014.05.010eter, energy of highest occupied molecular orbital (HOMO)
which led to best QSAR model for explaining antibacterial
activity of the synthesized compounds (Eq. 2) having improved
r and q2 values.
3.4.2. MLR mt-QSAR model for antibacterial activity
pMICab ¼ 0:0683 1vv  0:0406 HOMOþ 0:714 ð2Þ
n ¼ 14 r ¼ 0:920 q2 ¼ 0:759 s ¼ 0:0129 F ¼ 30:46
According to the FMO concept, the HOMO and LUMO of
a molecule play important roles in intermolecular interactions.
Extending the concept to binding in drug-receptor systems, theanticancer evaluation and QSAR studies of 2/3-bromo-N0-(substituted
e/3-phenylallylidene)benzohydrazides –>. Arabian Journal of Chemis-
8 P. Kumar et al.major contribution to binding involves the interaction between
the HOMO of the drug with the LUMO of the receptor and
that between LUMO of the drug with the HOMO of the recep-
tor. The extents of these stabilizing interactions are inversely
related to the energy gap between the interacting orbitals
(Jesudason et al., 2009).
The QSAR model expressed by Eq. (2) was cross validated
by its high q2 value (q2 = 0.759) obtained by leave one out
(LOO) method. The value of q2 greater than 0.5 is the basic
requirement for qualifying a QSAR model to be a valid one
(Golbraikh and Tropsha, 2002). As the observed and predicted
antibacterial activity values are close to each other (Table 5),
the mt-QSAR model for antibacterial activity (Eq. 2) is a valid
one. The plot of predicted pMICab against observed pMICab
(Fig. 2) also favors the developed QSAR model expressed by
Eq. (2). Further, the plot of observed pMICab vs. residual
pMICab (Fig. 3) indicated that there was no systemic error in
model development as the propagation of error was observed
on both sides of zero (Kumar et al., 2007).
Results of correlation of calculated molecular descriptors
with antifungal activity of the synthesized compounds indi-
cated that topological parameter, valence second order molec-
ular connectivity index (2vv) was most dominating descriptor
for antifungal activity of the synthesized compounds. So,
QSAR model for antifungal activity of the synthesized
benzohydrazides was developed by using the topological
parameter, valence second order molecular connectivity index
(2vv) (r= 0.685, Eq. (3)).
3.4.3. LR mt-QSAR model for antifungal activity
pMICaf ¼ 0:1932 vv þ 0:552 ð3Þ
n ¼ 13 r ¼ 0:685 q2 ¼ 0:282 s ¼ 0:0657 F ¼ 9:71
As in case of antibacterial activity, coefﬁcient of 2vv in Eq.
(3) is positive which indicates that antifungal activity of the
synthesized compounds is positively correlated to valence sec-
ond order molecular connectivity index (2vv) i.e. antifungal
activity of the synthesized compounds will increase with an
increase in value of 2vv and vice versa (Tables 2 and 4).
The validity and predictability of the QSAR model for anti-
fungal activity i.e. Eq. (3) were cross validated by q2 value
(q2 = 0.282) obtained by leave one out (LOO) method. The
value of q2 less than 0.5 indicated that the developed model
is an invalid one. But one should not forget the recommenda-
tions of Golbraikh and Tropsha (2002) who reported that the
only way to estimate the true predictive power of a model is to
test its ability to predict accurately the biological activities of
compounds. As the observed and predicted values are close
to each other (Table 5), the mt-QSAR model for antifungal
activity (Eq. 3) is therefore a valid one.
The mt-QSAR model of antimicrobial activity (Eq. 4)
depicted the importance of topological parameter, Balaban
index (J) in describing antimicrobial activity of the synthesized
compounds.
3.4.4. LR mt-QSAR model for antimicrobial activity
pMICam ¼ 0:424 Jþ 0:937 ð4Þ
n ¼ 13 r ¼ 0:757 q2 ¼ 0:471 s ¼ 0:021 F ¼ 14:78Please cite this article in press as: Kumar, P. et al., Synthesis, antimicrobial,
benzylidene/3-phenylallylidene)benzohydrazidesN0-(substituted benzyliden
try (2014), http://dx.doi.org/10.1016/j.arabjc.2014.05.010As in case of antibacterial and antifungal activities, coefﬁ-
cient of J in Eq. (4) is positive which indicates that antimicro-
bial activity of the synthesized compounds is positively
correlated to Balaban index (J) i.e. antimicrobial activity of
the synthesized compounds will increase with an increase in
value of J. This is evidenced by the antimicrobial activity data
of the synthesized compounds (Table 1) and their J values
(Table 3).
The topological parameters signify the degree of branching,
connectivity of atoms and the unsaturation in the molecule
which account for variation in activity. The topological
parameter, Balaban index J= J(G) of G is deﬁned as:
J ¼ M=ðlþ 1ÞRðdi:djÞ0:5Bonds
whereM is the number of bonds in G, l is the cyclomatic num-
ber of G, and di (i= 1,2,3, N; N is the number of vertices in G)
is the distance sum. The cyclomatic number l= l(G) of a cyc-
lic graph G is equal to the minimum number of edges necessary
to be erased from G in order to transform it into the related
acyclic graph. In case of monocyclic graph l= 1 otherwise
it is calculated by means of the following expression
(Balaban, 1982).
M ¼ lNþ 1:
In order to improve the value of correlation coefﬁcient (r),
we coupled Balaban index (J) with valence ﬁrst order molecu-
lar connectivity index (1vv) which improved the value of r from
0.757 to 0.808 and q2 from 0.471 to 0.515 (Eq. 5).
3.4.5. MLR mt-QSAR model for antimicrobial activity
pMICam ¼ 0:03141vv þ 0:272Jþ 0:944 ð5Þ
n ¼ 13 r ¼ 0:808 q2 ¼ 0:515 s ¼ 0:0198 F ¼ 9:43
The QSAR models expressed by Eq. (5) were cross vali-
dated by its high q2 values (q2 = 0. 515) obtained by leave
one out (LOO) method. The value of q2 greater than 0.5 is
the basic requirement for qualifying a QSAR model to be a
valid one (Golbraikh and Tropsha, 2002). As the observed
and predicted antimicrobial activity values are close to each
other (Table 5), the mt-QSAR model for antimicrobial activity
(Eq. 5) is a valid one. Further, high residual values (Table 5)
observed in case of outliers also justiﬁed their removal before
the development of QSAR models.
It was observed from mt-QSAR models (Eqs. (1)–(5)) that
the antibacterial, antifungal and overall antimicrobial activi-
ties of the synthesized 2/3-bromo-N0-(substituted benzyli-
dene/3-phenylallylidene)benzohydrazides was governed by
the topological parameters, Balaban index (J) and valence ﬁrst
and second order molecular connectivity indices (1vv and 2vv).
Generally for QSAR studies, the biological activities of
compounds should span 2–3 orders of magnitude. But in the
present study the range of antimicrobial activities of the syn-
thesized compounds is within one order of magnitude. This
is in accordance with results suggested by Bajaj et al. who sta-
ted that the reliability of the QSAR model lies in its predictive
ability even though the activity data are in the narrow range
(Bajaj et al., 2005). When biological activity data lie in the
narrow range, the presence of minimum standard deviation
of the biological activity justiﬁes its use in QSAR studies
(Narasimhan et al., 2007). The minimum standard deviationanticancer evaluation and QSAR studies of 2/3-bromo-N0-(substituted
e/3-phenylallylidene)benzohydrazides –>. Arabian Journal of Chemis-
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use in QSAR studies.
4. Conclusion
In conclusion, a series of substituted benzohydrazide deriva-
tives has been synthesized and its in vitro antimicrobial and
anticancer activities were evaluated against ﬁve representative
microorganisms and human colon (HCT116) cancer cell line.
The results of antimicrobial and anticancer study indicated
that compounds 3, 15 and 18 (pMICam = 1.62 lM/ml) were
found to be most potent antimicrobial agents and compound
4 (IC50 = 1.88 ± 0.03 lM) was found to be the most potent
anticancer agent. QSAR studies indicated the importance of
the topological parameters, Balaban index (J) and valence ﬁrst
and second order molecular connectivity indices (1vv and 2vv)
in describing the antimicrobial activity of the synthesized
benzohydrazides.Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.arabjc.
2014.05.010.
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